Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
400
Trial Sponsor
Clinical Trial Start Date
February 12, 2024
0Primary Completion Date
2026
0Study Completion Date
2027
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Other0
Intervention Type
Device0
Interventional Trial Phase
Not Applicable0
Participating Facility
Official Name
Characterizing the Scalp Tolerability of Transcranial Magnetic Stimulation by Location and Stimulation Parameters0
Last Updated
April 9, 2024
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Other attributes
Intervention Treatment
TMS Tolerability0
Study summary
The primary objective is to characterize the tolerability of TMS by scalp location (over parietal, motor, modified Beam F3 prefrontal, THREE-D prefrontal, orbitofrontal, and medial prefrontal) and stimulation parameters (single pulse, 10 Hz, theta burst). The secondary objective is to evaluate the knee as a surrogate location to safely trial tolerability of novel TMS parameters.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
